Rx Bandz, LLC SBIR Phase II Award, September 2023

A SBIR Phase II contract was awarded to Rx Bandz in September, 2023 for $1,799,613.0 USD from the U.S. Department of Defense and United States Air Force.

Overview Structured Data Issues Contributors Activity

sbir.gov/node/2568447

Is a

SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient

Rx Bandz

Government Agency

U.S. Department of Defense

Government Branch

United States Air Force

Award Type

SBIR0

Contract Number (US Government)

FA3016-23-C-00600

Award Phase

Phase II0

Award Amount (USD)

1,799,6130

Date Awarded

September 16, 2023

End Date

September 18, 2025

Abstract

The proposed TACFI effort seeks to continue, expand and refine the Phase II achievements with the goal of producing a hydromorphone auto-injector requested by the Air Force for immediately available point-of-injury care on remote and austere battlefields.